“Tocilizumab is not scientifically proven for COVID, so I would need to be careful about going in front of an audience and saying it is,” Koehne said. “If we had time, we could have a randomized trial over one or two years, and then prove the benefit of the drug in great detail. But we may have something helpful and we can’t afford to wait to find out,”